moxalactam has been researched along with aztreonam in 31 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (45.16) | 18.7374 |
1990's | 3 (9.68) | 18.2507 |
2000's | 9 (29.03) | 29.6817 |
2010's | 5 (16.13) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baquero, F; Canton, R; Gomez-Alferez, A; Loza, E; Martinez-Beltran, J | 1 |
Kuzui, H; Murakami, T; Nishino, T; Obana, Y | 1 |
Durgham, SM; Ishag, AH; Shibl, AM | 1 |
Evagelopoulou, V; Giamarellou, H; Lelekis, M | 1 |
Heimdahl, A; Kager, L; Nord, CE | 1 |
Baltch, AL; Bassey, C; Fanciullo, G; Smith, RP | 1 |
Elliott, CR; Pater, JL | 1 |
Marks, MI; Parker, KM; Stutman, HR | 1 |
Amicosante, G; Frère, JM; Galleni, M | 1 |
Androulakis, M; Giamarellou, H; Goumas, P; Petrikkos, G | 1 |
Asari, S; Hayashi, C; Horikawa, M; Kouda, K; Miyai, K; Tsukamoto, H | 1 |
Duff, P | 1 |
Bonner, DP; Clark, JM; Fernandes, PB; Kao, CC; Sykes, RB; Weinberg, DS | 1 |
Andrew, JH; Dixson, S | 1 |
Acar, JF; Goldstein, FW; Kitzis, MD | 1 |
Cullmann, W; Dick, W | 1 |
Borowiecka, B; Chojnowski, W; Pajchel, G | 1 |
Ishii, Y; Oguri, T; Shimizu-Ibuka, A | 1 |
Aubert, D; Naas, T; Nordmann, P; Ozcan, A | 1 |
Amicosante, G; Caporale, B; Celenza, G; Docquier, JD; Mezzatesta, M; Pellegrini, C; Perilli, M; Rossolini, GM; Stefani, S | 1 |
Girlich, D; Leclercq, R; Naas, T; Nordmann, P | 1 |
Doi, Y; Nordmann, P; Paterson, DL; Poirel, L | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L | 1 |
Castanheira, M; Samuelsen, Ø; Spencer, J; Walsh, TR | 1 |
Kanamori, M; Kirikae, T; Kitao, T; Miyoshi-Akiyama, T; Morita, K; Okazaki, M; Sekiguchi, J; Watanabe, N | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Girlich, D; Nordmann, P; Poirel, L | 3 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
1 review(s) available for moxalactam and aztreonam
Article | Year |
---|---|
Pathophysiology and management of postcesarean endomyometritis.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Cephalosporins; Cesarean Section; Clindamycin; Clinical Trials as Topic; Drug Therapy, Combination; Endometritis; Female; Gentamicins; Humans; Moxalactam; Penicillins; Postoperative Complications; Pregnancy; Socioeconomic Factors | 1986 |
3 trial(s) available for moxalactam and aztreonam
Article | Year |
---|---|
The effect of different measures of outcome on the results of studies of empiric antibiotic therapy in febrile neutropenic patients.
Topics: Acute Disease; Agranulocytosis; Anti-Bacterial Agents; Aztreonam; Clinical Trials as Topic; Cloxacillin; Drug Therapy, Combination; Fever; Humans; Infection Control; Leukemia; Lymphoma; Moxalactam; Multicenter Studies as Topic; Neoplasms; Neutropenia; Prognosis; Random Allocation; Tobramycin | 1988 |
A comparative study of cefoxitin, cefotaxime, moxalactam and aztreonam kinetics in saliva.
Topics: Aztreonam; Cefotaxime; Cefoxitin; Humans; Moxalactam; Saliva | 1987 |
Pathophysiology and management of postcesarean endomyometritis.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Cephalosporins; Cesarean Section; Clindamycin; Clinical Trials as Topic; Drug Therapy, Combination; Endometritis; Female; Gentamicins; Humans; Moxalactam; Penicillins; Postoperative Complications; Pregnancy; Socioeconomic Factors | 1986 |
28 other study(ies) available for moxalactam and aztreonam
Article | Year |
---|---|
The incidence and beta-lactam resistance of Proteus vulgaris in hospital infections: the last decade.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Aztreonam; Bacteremia; beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Moxalactam; Penicillins; Phenotype; Proteus Infections; Proteus vulgaris; Spain; Urinary Tract Infections | 1991 |
[Combination antibacterial effects between aztreonam and eight other antibiotics].
Topics: Amoxicillin; Animals; Aztreonam; Bacterial Infections; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Female; Gentamicins; Mice; Microscopy, Phase-Contrast; Moxalactam; Proteus vulgaris; Pseudomonas aeruginosa; Serratia marcescens | 1991 |
Comparative in vitro antibacterial activity of aztreonam against clinical isolates of gram-negative bacteria.
Topics: Aztreonam; Cefoperazone; Cefotaxime; Ceftazidime; Cross Infection; Gentamicins; Gram-Negative Bacteria; Moxalactam; Ticarcillin | 1989 |
Enhanced in-vitro bactericidal activity of amikacin combined with latamoxef, cefotaxime and aztreonam against multi-resistant Enterobacter cloacae.
Topics: Amikacin; Aztreonam; beta-Lactamases; Cefotaxime; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam; Time Factors | 1989 |
Alterations in the human oropharyngeal microflora related to therapy with aztreonam, moxalactam and ampicillin plus sulbactam.
Topics: Adult; Aged; Ampicillin; Aztreonam; Colon; Drug Combinations; Female; Gram-Negative Bacteria; Humans; Male; Middle Aged; Moxalactam; Oropharynx; Penicillanic Acid; Postoperative Complications; Premedication; Saliva; Sulbactam | 1986 |
In-vitro antimicrobial activity of enoxacin in combination with eight other antibiotics against Pseudomonas aeruginosa, Enterobacteriaceae and Staphylococcus aureus.
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefsulodin; Clindamycin; Drug Combinations; Drug Synergism; Enoxacin; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam; Naphthyridines; Oxacillin; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Vancomycin | 1987 |
Potential of moxalactam and other new antimicrobial agents for bilirubin-albumin displacement in neonates.
Topics: Anti-Bacterial Agents; Azlocillin; Aztreonam; Bilirubin; Binding Sites; Cefoperazone; Ciprofloxacin; Enoxacin; Humans; Imipenem; In Vitro Techniques; Infant, Newborn; Moxalactam; Naphthyridines; Quinolines; Serum Albumin; Thienamycins | 1985 |
A survey of the kinetic parameters of class C beta-lactamases. Cephalosporins and other beta-lactam compounds.
Topics: Aztreonam; beta-Lactamases; Cephalosporins; Hydrolysis; Imipenem; Kinetics; Moxalactam; Substrate Specificity | 1988 |
[Susceptibility of clinical isolates to aztreonam].
Topics: Aztreonam; Cefmetazole; Cefoperazone; Cefotaxime; Cefsulodin; Cephamycins; Microbial Sensitivity Tests; Moxalactam | 1987 |
Evaluation of aztreonam, cefoperazone, latamoxef and ceftazidime in the hamster colitis model.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; Bacterial Toxins; Cecum; Cefoperazone; Ceftazidime; Clindamycin; Colitis; Cricetinae; Disease Models, Animal; Drug Evaluation; Injections, Intraperitoneal; Male; Mesocricetus; Moxalactam | 1986 |
The in vitro activity of the newer beta-lactam antibiotics against 124 strains of gram-negative bacilli.
Topics: Anti-Bacterial Agents; Azlocillin; Aztreonam; Cephalosporins; Enterobacteriaceae; Gentamicins; Imipenem; Microbial Sensitivity Tests; Moxalactam; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Ticarcillin | 1985 |
In-vitro activity of SQ 26,776 against multiply-resistant enterobacteria--preliminary results.
Topics: Anti-Bacterial Agents; Aztreonam; Cefotaxime; Cephamycins; Drug Resistance, Microbial; Enterobacteriaceae; Lactams; Moxalactam | 1981 |
Investigations on beta-lactamase stability of recently developed beta-lactam compounds: study of enzyme kinetics.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Citrobacter; Enterobacter; Enterobacteriaceae; Escherichia coli; Imipenem; Moxalactam; Thienamycins | 1983 |
[Determination of moxalactam, aztreonam and imipenem by the perchloric hydroxylamine method].
Topics: Anti-Bacterial Agents; Aztreonam; Drug Stability; Hydroxylamine; Hydroxylamines; Imipenem; Moxalactam | 1992 |
Conformational Change Observed in the Active Site of Class C β-Lactamase MOX-1 upon Binding to Aztreonam.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; Binding Sites; Carbon Dioxide; Catalytic Domain; Crystallography, X-Ray; Drug Resistance, Multiple, Bacterial; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Molecular; Moxalactam; Protein Conformation; Substrate Specificity | 2015 |
Chromosome-encoded narrow-spectrum Ambler class A beta-lactamase GIL-1 from Citrobacter gillenii.
Topics: beta-Lactamases; Chromosomes; Chromosomes, Bacterial; Citrobacter; Cloning, Molecular; DNA, Bacterial; Escherichia coli; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Genes, Bacterial; Molecular Sequence Data | 2007 |
Identification and characterization of a new metallo-beta-lactamase, IND-5, from a clinical isolate of Chryseobacterium indologenes.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Chryseobacterium; Flavobacteriaceae Infections; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Sequence Analysis, DNA | 2007 |
Molecular and biochemical characterization of the chromosome-encoded class A beta-lactamase BCL-1 from Bacillus clausii.
Topics: Amino Acid Sequence; Bacillus; Bacterial Proteins; beta-Lactamases; Chromosome Mapping; Chromosomes, Bacterial; Cloning, Molecular; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Weight; Sequence Homology, Amino Acid; Substrate Specificity | 2007 |
Characterization of a naturally occurring class D beta-lactamase from Achromobacter xylosoxidans.
Topics: Achromobacter denitrificans; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cloning, Molecular; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey | 2008 |
Kinetic characterization of VIM-7, a divergent member of the VIM metallo-beta-lactamase family.
Topics: Acremonium; Bacterial Proteins; beta-Lactamases; Catalysis; Catalytic Domain; Cefepime; Ceftazidime; Cephalosporins; Kinetics; Models, Molecular; Mutation; Penicillinase; Protein Structure, Tertiary; Recombinant Proteins; Structure-Activity Relationship; Substrate Specificity | 2008 |
KHM-1, a novel plasmid-mediated metallo-beta-lactamase from a Citrobacter freundii clinical isolate.
Topics: Amino Acid Sequence; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Citrobacter freundii; Conjugation, Genetic; DNA Primers; DNA, Bacterial; Enterobacteriaceae Infections; Escherichia coli K12; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Recombinant Proteins; Sequence Homology, Amino Acid | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate.
Topics: Acinetobacter baumannii; beta-Lactamases; DNA, Bacterial; Escherichia coli; France; Genes, Bacterial; Water Microbiology | 2010 |
Novel ambler class A carbapenem-hydrolyzing beta-lactamase from a Pseudomonas fluorescens isolate from the Seine River, Paris, France.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Blotting, Southern; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; France; Fresh Water; Gram-Negative Bacteria; Health Surveys; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Pseudomonas fluorescens; Water Microbiology | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
PER-6, an extended-spectrum beta-lactamase from Aeromonas allosaccharophila.
Topics: Aeromonas; Animals; Base Sequence; beta-Lactamases; DNA Primers; DNA, Bacterial; Genes, Bacterial; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Paris; Water Microbiology | 2010 |